Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New analgesic agents from Gruenenthal

Feb. 3, 1998

Synthelabo claims mixed and specific dopamine receptor ligands

Feb. 3, 1998

Xerecept shows promise in patients with brain tumors

Feb. 2, 1998

Glutamate antagonists: a new frontier in stroke research

Feb. 2, 1998

Lipid peroxidation inhibitor discovered in marine sponge by team at Kirin Brewery and U. of Tokyo

Feb. 2, 1998

AMPA receptor antagonists disclosed by Pfizer

Feb. 2, 1998

New anticonvulsants under study at Bristol-Myers Squibb

Feb. 2, 1998

Pharmacia & Upjohn licenses rights to Spanish antimigraine drug

Jan. 30, 1998

Antiemetic to be copromoted in Japan by Novartis and Kyowa Hakko

Jan. 30, 1998

Phase II results reported for memantine in neuropathic pain

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...